AIRC 2020- A druggable approach to modulate cancer epigenetics. AIRC 2020- A druggable approach to modulate cancer epigenetics.

AIRC 2021 - Reverse the silencing: Targeting the MEF2-class IIa HDACs axis in leiomyosarcomas. AIRC 2021 - Reverse the silencing: Targeting the MEF2-class IIa HDACs axis in leiomyosarcomas.

AIRC 2023 - Deciphering the molecular mechanisms driving the interplay between tumor-associated immune cells and cancer cells AIRC 2023 - Deciphering the molecular mechanisms driving the interplay between tumor-associated immune cells and cancer cells

Study of the amyloidogenic conversion of V30M, S52P and V122I transthyretin variants by real-time Nuclear Magnetic Resonance: elucidation of the molecular mechanisms leading to different ATTR amyloidosis severity and different drug response. Study of the amyloidogenic conversion of V30M, S52P and V122I transthyretin variants by real-time Nuclear Magnetic Resonance: elucidation of the molecular mechanisms leading to different ATTR amyloidosis severity and different drug response.